Abstract
Background The viral dynamics and the role of children in the spread of SARS-CoV-2 are not completely understood. Our aim was to evaluate RT-PCR Ct values among children with confirmed SARS-CoV-2 compared with that of adult subjects.
Methods Patients (aged from 2 months to ≤18 years, and adults) with signs and symptoms of acute SARS-CoV-2 infection for less than 7 days, were prospectively enrolled in the study from May to November 2020. All participants performed RT-PCR assay for SARS-CoV-2 detection; Ct values of ORF1ab, N, and S gene-targets, and the average of all the three probes were used as surrogates of viral load.
Results There were 21 infants, 62 children and 293 adults of 376 participants with confirmed SARS-CoV-2 infections. RT-PCR Ct values of children under 18 were not significantly different from that of adults after adjusting for days of illness, as observed by the analyzed probes (namely ORF1ab, N, and S), and by the mean of all 3 gene-targets.
Conclusions Ct values for children were comparable to that of adults. Days of illness are a major confounder for SARS-CoV-2 viral load and must be adjusted in any comparison. Although viral load is not the only determinant of SARS-CoV-2 transmission, children may play a significant role in the spread of in the community.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Ministry of Health of Brazil, through the Institutional Development Program of the Brazilian National Health System (PROAD-SUS) in collaboration with Hospital Moinhos de Vento.The Ministry of Health had no role in study design, sample and data collection, data analysis and interpretation, and in the decision to submit the article for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was performed in accordance with the declaration of Helsinki and Good Clinical Practice Guidelines, after approval by the Hospital Moinhos de Vento Institutional Review Board (IRB number 30749720.4.1001.5330) submitted April 14th, 2020 and a decision made April 17th, 2020 (decision number 3.977.144). All participants included in this study provided either a written informed consent, or a legal responsible provided written informed consent.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.